Skip to main content
. 2023 Jun 5;2023(6):CD014915. doi: 10.1002/14651858.CD014915.pub2

1.6. Analysis.

1.6

Comparison 1: Nabiximols (tetrahydrocannabinol (THC) and cannabidiol (CBD)) versus placebo for individuals with opioid‐refractory cancer pain, Outcome 6: Sleep problems